Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. ACN

Go back to Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
(NASDAQ: RLMD) Delayed: 4.16 +0.04 (0.97%)
Previous Close $4.12    52 Week High $4.10 
Open $4.13    52 Week Low $0.87 
Day High $4.24    P/E N/A 
Day Low $4.08    EPS $0.00 
Volume 551,635